These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38726688)

  • 1. Development and initial validation of the Scale of Scales (SOS) overreporting scores for the MMPI family of instruments.
    Ingram PB; Keen MA; Greene TE; Morris C; Armistead-Jehle PJ
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):95-110. PubMed ID: 38726688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Generalizability of Overreporting Across Self-Report Measures: An Investigation With the Minnesota Multiphasic Personality Inventory-2-Restructured Form and the Personality Assessment Inventory in a Civil Disability Sample.
    Crighton AH; Tarescavage AM; Gervais RO; Ben-Porath YS
    Assessment; 2017 Jul; 24(5):555-574. PubMed ID: 26676916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative capacity of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and MMPI-2 Restructured Form (MMPI-2-RF) validity scales to detect suspected malingering in a disability claimant sample.
    Chmielewski M; Zhu J; Burchett D; Bury AS; Bagby RM
    Psychol Assess; 2017 Feb; 29(2):199-208. PubMed ID: 27183046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the MMPI-3 validity scales for detecting overreporting and underreporting and their effects on substantive scale validity: A simulation study.
    Whitman MR; Tylicki JL; Ben-Porath YS
    Psychol Assess; 2021 May; 33(5):411-426. PubMed ID: 33630633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An examination of the MMPI-3 validity scales in detecting overreporting of psychological problems.
    Reeves CK; Brown TA; Sellbom M
    Psychol Assess; 2022 Jun; 34(6):517-527. PubMed ID: 35201824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification accuracy of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2)-Restructured form validity scales in detecting malingered pain-related disability.
    Bianchini KJ; Aguerrevere LE; Curtis KL; Roebuck-Spencer TM; Frey FC; Greve KW; Calamia M
    Psychol Assess; 2018 Jul; 30(7):857-869. PubMed ID: 29072481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Moderating Influence of Disorder on Coached Overreporting Using the MMPI-2-RF.
    Olsen AM; Veltri COC
    J Pers Assess; 2019; 101(3):264-273. PubMed ID: 29792532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating the usefulness of the NSI validity-10 with the MMPI-2-RF.
    Gradwohl BD; Mangum RW; Tolle KA; Pangilinan PH; Bieliauskas LA; Spencer RJ
    Int J Neurosci; 2020 Sep; 130(9):926-932. PubMed ID: 31928283
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross validation of the response bias scale and the response bias scale-19 in active-duty personnel: use on the MMPI-2-RF and MMPI-3.
    Ingram PB; Armistead-Jehle P; Childers LG; Herring TT
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):141-151. PubMed ID: 38493366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the disorder matter? Investigating a moderating effect on coached noncredible overreporting using the MMPI-2 and PAI.
    Veltri CO; Williams JE
    Assessment; 2013 Apr; 20(2):199-209. PubMed ID: 23118265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of the association between psychopathy and dissimulation using the MMPI-2-RF validity scales.
    Marion BE; Sellbom M; Salekin RT; Toomey JA; Kucharski LT; Duncan S
    Law Hum Behav; 2013 Aug; 37(4):219-30. PubMed ID: 22799603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of overreporting on MMPI-2-RF substantive scale score validity.
    Burchett DL; Ben-Porath YS
    Assessment; 2010 Dec; 17(4):497-516. PubMed ID: 20739584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the relationship between symptom and performance validity measures across referral subtypes.
    Boress K; Gaasedelen O; Kim JH; Basso MR; Whiteside DM
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):162-171. PubMed ID: 37791494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the MMPI-2-RF and PAI overreporting indicators in a civil forensic sample with emphasis on the Response Bias Scale (RBS) and the Cognitive Bias Scale (CBS).
    Tylicki JL; Rai JK; Arends P; Gervais RO; Ben-Porath YS
    Psychol Assess; 2021 Jan; 33(1):71-83. PubMed ID: 33090826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting feigned ADHD in college students using the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF).
    Morris NM; Lee TTC; Demakis GJ; Park S
    Clin Neuropsychol; 2023 Aug; 37(6):1154-1172. PubMed ID: 35980751
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusters of financially incentivized chronic pain patients using the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF).
    Aguerrevere LE; Calamia MR; Greve KW; Bianchini KJ; Curtis KL; Ramirez V
    Psychol Assess; 2018 May; 30(5):634-644. PubMed ID: 28627924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobehavioral symptom validity in U.S. Department of Veterans Affairs (VA) mild traumatic brain injury evaluations.
    Ashendorf L
    J Clin Exp Neuropsychol; 2019 May; 41(4):432-441. PubMed ID: 30712457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.